New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What has been Investigated and What is in the Pipeline? [PDF]
A wide range of support is available to help smokers to quit and aid attempts at harm reduction, including three first-line smoking cessation medications: nicotine replacement therapy, varenicline and bupropion.
A Bisaga +293 more
core +1 more source
Background: The effects of the combination therapy of varenicline and bupropion in smoking cessation are still controversial. Methods: Databases including PubMed, EMBASE, Cochrane Library and Web of Science were scanned without time and language ...
Zhaoshuang Zhong +3 more
doaj +1 more source
Four patients with a history of acute exacerbations of COPD: implementing the CHEST/Canadian Thoracic Society guidelines for preventing exacerbations [PDF]
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if ...
A Singanayagam +43 more
core +1 more source
Efficacy of Varenicline in Smoking Cessation—A Systematic Review and Meta-analysis
Background: Tobacco use is a leading cause of morbidity and mortality. Smoking cessation significantly reduces related health risks. Varenicline, a partial nicotine receptor agonist, may aid cessation by reducing cigarette consumption and dependence ...
Reethu Ravichandiran +5 more
doaj +1 more source
A validated stability-indicating HPLC method for determination of varenicline in its bulk and tablets [PDF]
A simple, sensitive and accurate stability-indicating HPLC method has been developed and validated for determination of varenicline (VRC) in its bulk form and pharmaceutical tablets.
Adnan A Kadi +3 more
core +1 more source
Real world evaluation of three models of NHS smoking cessation service in England [PDF]
Background NHS Stop Smoking Services provide various options for support and counselling. Most services have evolved to suit local needs without any retrospective evaluation of their efficiency.
Tony Mardle +4 more
core +2 more sources
Varenicline-induced manic episode
Varenicline is a novel antismoking agent that reduces cravings and blocks pleasure of nicotine by serving as a partial agonist to the nicotinic receptor Varenicline has been associated with some important psychiatric adverseeffects for the patients with ...
Omer Gecici +2 more
doaj +1 more source
Impact of Continuing Education on Clinicians' Self- Reported Knowledge of Tobacco Dependence and Tobacco Control Interventions [PDF]
Purpose: To assess a tobacco cessation continuing education (CE) program for Indiana dental and medical providers. Methods: A 26-item immediate post-CE survey and a 19-item 3-month follow-up survey assessed changes in participants’ self-reported ...
Coan, Lorinda, Romito, Laura M.
core
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. [PDF]
n/
DE MICHELE, GIUSEPPE +2 more
core +1 more source
Vareniclina en el tratamiento del tabaquismo: efi cacia y seguridad en población general, psiquiátrica y drogodependiente [PDF]
Desde el año 2006 la vareniclina se está utilizando como tratamiento de primera elección para dejar de fumar. La mayoría de estudios publicados sobre efi cacia y seguridad de este producto se han hecho sobre muestras de fumadores sanos.
Ballbè Gibernau, Montse +6 more
core

